Pregnancy

Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use…

1 month ago

Stryker launches next generation of SurgiCount+ to help improve the standard of care in hospitals for sponge management and blood loss assessment

PORTAGE, Mich., USA, Nov. 14, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced its launch of the…

1 month ago

This Giving Tuesday and Colorado Gives Day, Empower Women to Choose Motherhood Through Save the Storks

COLORADO SPRINGS, Colo., Nov. 14, 2024 /PRNewswire/ -- With 31%* of regions in the United States labeled "maternity healthcare deserts," Save…

1 month ago

The Sigourney Award-2024 Recipients Honored For Outstanding Work Advancing Psychoanalytic Principles Globally

Four Recipients' Work From Israel, Sweden, Canada and South Africa Earns The Sigourney Award-2024 SEATTLE, Nov. 12, 2024 /PRNewswire/ --…

1 month ago

Pacify Health Expands Doula-Led Maternity Care with Acquisition of Family Ways

ARLINGTON, Va., Nov. 12, 2024 /PRNewswire/ -- Pacify, a leader in tech-enabled maternity care solutions, proudly announces its acquisition of…

1 month ago

SURVEY SAYS: WHAT ONE-THIRD OF FIRST-TIME PARENTS WISHED THEY DID (OR KNEW) WHEN BRINGING BABY HOME

Research Shows First-Time Parents 'Longed for More' in Reflecting on Who they Wish They Were DOVER, Del., Nov. 12, 2024…

1 month ago

ENHERTU® Receives Prestigious 2024 Prix Galien USA Award for Best Biotechnology Product

TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo (TSE:4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have been awarded The Galien Foundation 2024 Prix…

1 month ago

Travere Therapeutics Presents Data Reinforcing Clinical Benefit of FILSPARI® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024

Nearly 60% of patients with IgAN in the SPARTAN Study achieved complete remission when using FILSPARI as first-line treatment SPARTACUS…

2 months ago